CN105963389B - The separation method of anti-high altitude anoxia anti-fatigue activity ingredient and its application in cape jasmine - Google Patents
The separation method of anti-high altitude anoxia anti-fatigue activity ingredient and its application in cape jasmine Download PDFInfo
- Publication number
- CN105963389B CN105963389B CN201610305926.0A CN201610305926A CN105963389B CN 105963389 B CN105963389 B CN 105963389B CN 201610305926 A CN201610305926 A CN 201610305926A CN 105963389 B CN105963389 B CN 105963389B
- Authority
- CN
- China
- Prior art keywords
- cape jasmine
- column
- group
- high altitude
- fatigue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 244000111489 Gardenia augusta Species 0.000 title claims abstract description 112
- 235000018958 Gardenia augusta Nutrition 0.000 title claims abstract description 98
- 206010021143 Hypoxia Diseases 0.000 title claims abstract description 64
- 206010002660 Anoxia Diseases 0.000 title claims abstract description 55
- 241000976983 Anoxia Species 0.000 title claims abstract description 55
- 230000007953 anoxia Effects 0.000 title claims abstract description 55
- 230000000694 effects Effects 0.000 title claims abstract description 48
- 230000002929 anti-fatigue Effects 0.000 title claims abstract description 37
- 239000004615 ingredient Substances 0.000 title claims abstract description 30
- 238000000926 separation method Methods 0.000 title claims abstract description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 187
- SEBIKDIMAPSUBY-ARYZWOCPSA-N Crocin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)C(C)=CC=CC(C)=C\C=C\C=C(/C)\C=C\C=C(C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SEBIKDIMAPSUBY-ARYZWOCPSA-N 0.000 claims abstract description 103
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 88
- 239000009627 gardenia yellow Substances 0.000 claims abstract description 84
- 239000004952 Polyamide Substances 0.000 claims abstract description 54
- 229920002647 polyamide Polymers 0.000 claims abstract description 54
- 239000011347 resin Substances 0.000 claims abstract description 45
- 229920005989 resin Polymers 0.000 claims abstract description 45
- 230000002829 reductive effect Effects 0.000 claims abstract description 43
- 239000000243 solution Substances 0.000 claims abstract description 38
- 239000012153 distilled water Substances 0.000 claims abstract description 34
- XJMPAUZQVRGFRE-AYDWLWLASA-N methyl (1s,4as,7s,7as)-7-hydroxy-7-(hydroxymethyl)-1-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,7a-dihydro-1h-cyclopenta[c]pyran-4-carboxylate Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1[C@](C=C2)(O)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O XJMPAUZQVRGFRE-AYDWLWLASA-N 0.000 claims abstract description 33
- XJMPAUZQVRGFRE-SCHFUKFYSA-N Gardenoside Natural products O=C(OC)C=1[C@H]2[C@H]([C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)OC=1)[C@@](O)(CO)C=C2 XJMPAUZQVRGFRE-SCHFUKFYSA-N 0.000 claims abstract description 28
- 238000010828 elution Methods 0.000 claims abstract description 25
- 239000007864 aqueous solution Substances 0.000 claims abstract description 19
- 238000011010 flushing procedure Methods 0.000 claims abstract description 17
- 238000001035 drying Methods 0.000 claims abstract description 16
- 238000011068 loading method Methods 0.000 claims abstract description 16
- 239000000843 powder Substances 0.000 claims abstract description 16
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 12
- 238000001914 filtration Methods 0.000 claims abstract description 8
- 239000012535 impurity Substances 0.000 claims abstract description 8
- 235000019441 ethanol Nutrition 0.000 claims description 66
- 230000003078 antioxidant effect Effects 0.000 claims description 24
- 239000003963 antioxidant agent Substances 0.000 claims description 21
- 235000006708 antioxidants Nutrition 0.000 claims description 21
- 239000007788 liquid Substances 0.000 claims description 20
- 239000007924 injection Substances 0.000 claims description 16
- 238000002347 injection Methods 0.000 claims description 16
- 238000000605 extraction Methods 0.000 claims description 14
- 239000003814 drug Substances 0.000 claims description 13
- 239000000470 constituent Substances 0.000 claims description 10
- 239000002552 dosage form Substances 0.000 claims description 9
- 238000009835 boiling Methods 0.000 claims description 8
- NWCHELUCVWSRRS-SECBINFHSA-N (2r)-2-hydroxy-2-phenylpropanoic acid Chemical class OC(=O)[C@@](O)(C)C1=CC=CC=C1 NWCHELUCVWSRRS-SECBINFHSA-N 0.000 claims description 7
- 238000005267 amalgamation Methods 0.000 claims description 7
- 238000000889 atomisation Methods 0.000 claims description 7
- 238000004821 distillation Methods 0.000 claims description 7
- 239000003826 tablet Substances 0.000 claims description 6
- 239000000049 pigment Substances 0.000 claims description 5
- 239000007919 dispersible tablet Substances 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- 239000007910 chewable tablet Substances 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- 239000008298 dragée Substances 0.000 claims description 3
- 239000007941 film coated tablet Substances 0.000 claims description 3
- 239000007902 hard capsule Substances 0.000 claims description 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 239000007901 soft capsule Substances 0.000 claims description 3
- 239000004575 stone Substances 0.000 claims description 3
- 239000007940 sugar coated tablet Substances 0.000 claims description 3
- 239000006188 syrup Substances 0.000 claims description 3
- 235000020357 syrup Nutrition 0.000 claims description 3
- 239000007938 effervescent tablet Substances 0.000 claims description 2
- 241000157835 Gardenia Species 0.000 claims 2
- 238000005507 spraying Methods 0.000 claims 1
- 238000004108 freeze drying Methods 0.000 abstract description 11
- 238000000034 method Methods 0.000 abstract description 5
- 239000003480 eluent Substances 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 240000001972 Gardenia jasminoides Species 0.000 abstract 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 80
- -1 effervesce Piece Substances 0.000 description 38
- 239000000047 product Substances 0.000 description 33
- 210000004185 liver Anatomy 0.000 description 27
- 210000003205 muscle Anatomy 0.000 description 25
- 210000002966 serum Anatomy 0.000 description 22
- 238000012360 testing method Methods 0.000 description 22
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 20
- 230000002000 scavenging effect Effects 0.000 description 19
- 239000000284 extract Substances 0.000 description 18
- 238000002835 absorbance Methods 0.000 description 17
- 238000002474 experimental method Methods 0.000 description 17
- 241001465754 Metazoa Species 0.000 description 16
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 16
- 210000001519 tissue Anatomy 0.000 description 15
- SEBIKDIMAPSUBY-JAUCNNNOSA-N Crocin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C=CC=C(/C)C(=O)OC3OC(COC4OC(CO)C(O)C(O)C4O)C(O)C(O)C3O SEBIKDIMAPSUBY-JAUCNNNOSA-N 0.000 description 14
- 239000008280 blood Substances 0.000 description 13
- 239000002775 capsule Substances 0.000 description 13
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 12
- 210000004072 lung Anatomy 0.000 description 12
- 241000699670 Mus sp. Species 0.000 description 11
- 244000042430 Rhodiola rosea Species 0.000 description 11
- 235000003713 Rhodiola rosea Nutrition 0.000 description 11
- 239000001301 oxygen Substances 0.000 description 11
- 229910052760 oxygen Inorganic materials 0.000 description 11
- 241001165494 Rhodiola Species 0.000 description 10
- 150000002632 lipids Chemical class 0.000 description 10
- 102000004190 Enzymes Human genes 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- 239000000287 crude extract Substances 0.000 description 9
- 229940088598 enzyme Drugs 0.000 description 9
- 230000009182 swimming Effects 0.000 description 9
- 102000013009 Pyruvate Kinase Human genes 0.000 description 8
- 108020005115 Pyruvate Kinase Proteins 0.000 description 8
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 8
- 239000003153 chemical reaction reagent Substances 0.000 description 8
- 239000004310 lactic acid Substances 0.000 description 8
- 235000014655 lactic acid Nutrition 0.000 description 8
- 210000004556 brain Anatomy 0.000 description 7
- 230000007954 hypoxia Effects 0.000 description 7
- 150000003254 radicals Chemical class 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- PANKHBYNKQNAHN-JTBLXSOISA-N Crocetin Natural products OC(=O)C(\C)=C/C=C/C(/C)=C\C=C\C=C(\C)/C=C/C=C(/C)C(O)=O PANKHBYNKQNAHN-JTBLXSOISA-N 0.000 description 6
- 229920002527 Glycogen Polymers 0.000 description 6
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 6
- PANKHBYNKQNAHN-JUMCEFIXSA-N carotenoid dicarboxylic acid Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)O)C=CC=C(/C)C(=O)O PANKHBYNKQNAHN-JUMCEFIXSA-N 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- PANKHBYNKQNAHN-MQQNZMFNSA-N crocetin Chemical compound OC(=O)C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)C(O)=O PANKHBYNKQNAHN-MQQNZMFNSA-N 0.000 description 6
- 229960003180 glutathione Drugs 0.000 description 6
- 150000004676 glycans Chemical class 0.000 description 6
- 229940096919 glycogen Drugs 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000003647 oxidation Effects 0.000 description 6
- 238000007254 oxidation reaction Methods 0.000 description 6
- 238000003825 pressing Methods 0.000 description 6
- 239000012488 sample solution Substances 0.000 description 6
- 210000000813 small intestine Anatomy 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 5
- 241000005787 Cistanche Species 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 230000003064 anti-oxidating effect Effects 0.000 description 5
- 230000003035 anti-peroxidant effect Effects 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 5
- 238000011049 filling Methods 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 238000001694 spray drying Methods 0.000 description 5
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 238000004378 air conditioning Methods 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 238000001802 infusion Methods 0.000 description 4
- 239000000787 lecithin Substances 0.000 description 4
- 229940067606 lecithin Drugs 0.000 description 4
- 235000010445 lecithin Nutrition 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 239000008055 phosphate buffer solution Substances 0.000 description 4
- 229940107700 pyruvic acid Drugs 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 244000020518 Carthamus tinctorius Species 0.000 description 3
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 230000008499 blood brain barrier function Effects 0.000 description 3
- 210000001218 blood-brain barrier Anatomy 0.000 description 3
- 235000021466 carotenoid Nutrition 0.000 description 3
- 150000001747 carotenoids Chemical class 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000005485 electric heating Methods 0.000 description 3
- 230000034659 glycolysis Effects 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000003859 lipid peroxidation Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 206010048962 Brain oedema Diseases 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 244000089742 Citrus aurantifolia Species 0.000 description 2
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 2
- 101710088194 Dehydrogenase Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 108060001084 Luciferase Proteins 0.000 description 2
- 239000005089 Luciferase Substances 0.000 description 2
- 241000123069 Ocyurus chrysurus Species 0.000 description 2
- 229930040373 Paraformaldehyde Natural products 0.000 description 2
- 206010037423 Pulmonary oedema Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 235000011941 Tilia x europaea Nutrition 0.000 description 2
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- APUPEJJSWDHEBO-UHFFFAOYSA-P ammonium molybdate Chemical compound [NH4+].[NH4+].[O-][Mo]([O-])(=O)=O APUPEJJSWDHEBO-UHFFFAOYSA-P 0.000 description 2
- 239000011609 ammonium molybdate Substances 0.000 description 2
- 235000018660 ammonium molybdate Nutrition 0.000 description 2
- 229940010552 ammonium molybdate Drugs 0.000 description 2
- 230000010100 anticoagulation Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 208000006752 brain edema Diseases 0.000 description 2
- 210000005013 brain tissue Anatomy 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 2
- 230000001146 hypoxic effect Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 2
- 239000004571 lime Substances 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 238000000399 optical microscopy Methods 0.000 description 2
- 229920002866 paraformaldehyde Polymers 0.000 description 2
- 239000000276 potassium ferrocyanide Substances 0.000 description 2
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 2
- 235000019394 potassium persulphate Nutrition 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 235000011008 sodium phosphates Nutrition 0.000 description 2
- 239000004334 sorbic acid Substances 0.000 description 2
- 238000012109 statistical procedure Methods 0.000 description 2
- 239000008227 sterile water for injection Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- XOGGUFAVLNCTRS-UHFFFAOYSA-N tetrapotassium;iron(2+);hexacyanide Chemical compound [K+].[K+].[K+].[K+].[Fe+2].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] XOGGUFAVLNCTRS-UHFFFAOYSA-N 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- BNGXYYYYKUGPPF-UHFFFAOYSA-M (3-methylphenyl)methyl-triphenylphosphanium;chloride Chemical compound [Cl-].CC1=CC=CC(C[P+](C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 BNGXYYYYKUGPPF-UHFFFAOYSA-M 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical class N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- 208000002381 Brain Hypoxia Diseases 0.000 description 1
- CZSBHMFVVLYIQQ-RDVATZJHSA-N Crocin 2 Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C=CC=C(/C)C(=O)OC3OC(CO)C(O)C(O)C3O CZSBHMFVVLYIQQ-RDVATZJHSA-N 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 108010059881 Lactase Proteins 0.000 description 1
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 102000019259 Succinate Dehydrogenase Human genes 0.000 description 1
- 108010012901 Succinate Dehydrogenase Proteins 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 230000000141 anti-hypoxic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- CZSBHMFVVLYIQQ-DRVLGOCHSA-N beta-D-gentiobiosyl beta-D-glucosyl crocetin Chemical compound O([C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)C(=O)C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)C(=O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O CZSBHMFVVLYIQQ-DRVLGOCHSA-N 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000006567 cellular energy metabolism Effects 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 239000008845 cholagoga Substances 0.000 description 1
- 229940124571 cholagogue Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- SEBIKDIMAPSUBY-RTJKDTQDSA-N crocin-1 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SEBIKDIMAPSUBY-RTJKDTQDSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- RMDMBHQVNHQDDD-VFWKRBOSSA-L disodium;(2e,4e,6e,8e,10e,12e,14e)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate Chemical class [Na+].[Na+].[O-]C(=O)C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)C([O-])=O RMDMBHQVNHQDDD-VFWKRBOSSA-L 0.000 description 1
- XEYBHCRIKKKOSS-UHFFFAOYSA-N disodium;azanylidyneoxidanium;iron(2+);pentacyanide Chemical compound [Na+].[Na+].[Fe+2].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].[O+]#N XEYBHCRIKKKOSS-UHFFFAOYSA-N 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 210000003989 endothelium vascular Anatomy 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229910001447 ferric ion Inorganic materials 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 150000002275 gentiobioses Chemical class 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 230000001435 haemodynamic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 231100000567 intoxicating Toxicity 0.000 description 1
- 230000002673 intoxicating effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 229940116108 lactase Drugs 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- HKOOXMFOFWEVGF-UHFFFAOYSA-N phenylhydrazine Chemical compound NNC1=CC=CC=C1 HKOOXMFOFWEVGF-UHFFFAOYSA-N 0.000 description 1
- 229940067157 phenylhydrazine Drugs 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 235000007715 potassium iodide Nutrition 0.000 description 1
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 1
- 229940076788 pyruvate Drugs 0.000 description 1
- 210000003314 quadriceps muscle Anatomy 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 229940083618 sodium nitroprusside Drugs 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B61/00—Dyes of natural origin prepared from natural sources, e.g. vegetable sources
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention relates to a kind of separation methods of high altitude anoxia anti-fatigue activity ingredient anti-in cape jasmine, method includes the following steps: after (1) mentioning cape jasmine fruit water, through filtering, concentration, drying to get gardenia powder;(2) gardenia powder is configured to aqueous solution;(3) by step, (2) resulting aqueous solution injects processed polyamide column, then with distilled water flushing, respectively obtains polyamide column loading efflux, water elution;(4) processed macroporous resin column is injected after merging polyamide loading efflux and water elution, and to get Gardenoside product after elution, reduced pressure, freeze-drying;First with 10 ~ 30% ethanol solution rinse polyamide column removal of impurities, then with 30 ~ 90% ethanol solution flushing polyamide column, obtain 30 ~ 90% ethanol eluate, the eluent be concentrated under reduced pressure, be freeze-dried after to get Gardenia Yellow product.Meanwhile the application of the disclosed Gardenia Yellow of the present invention.The invention is simple and feasible, easy to operate, can industrialized production.
Description
Technical field
The present invention relates to high altitude anoxia anti-fatigue activity anti-in the process of enriching of Chinese herbal medicine effective ingredients more particularly to cape jasmine at
The separation method divided and its application.
Background technique
After people from Plain enters plateau, due to the environmental factors such as highlands rarefaction of air, atmosphere force down, partial pressure of oxygen is low, directly
Connect the physical strength and military operation ability for influencing body.Wherein, influence of the Altitude to body is the most obvious, in high altitude anoxia ring
After being engaged in certain physical strength or mental labour under border, blood lactase acid and other metabolins is easily caused to accumulate, and cause body generation
Thanking property acid-base disturbance is generally reduced so that muscle tone declines and cause the generation of fatigue phenomenon to show labour capacity,
Serious person loses work capacity.With the promotion of height above sea level, labour capacity is substantially reduced.Therefore, try to explore tired with resisting
The medicine of work is product highly important, that screening effectively prevents and relieves fatigue, for improving altitude environment lower body
Physical work capacity, relieve fatigue for quality of making the life better, improve working efficiency and military operation ability have it is positive
Meaning.
Cape jasmine be madder wort cape jasmine (Gardenia jasminoidesEllis dry mature fruit), for clinic
Conventional Chinese medicine.Its bitter cold in nature, it is nontoxic, enter the heart, liver, lung, tri-jiao channel, with purging intense heat relieving restlessness, reducing fever and causing diuresis, removing pattogenic heat from the blood and toxic material from the body function
Effect.Pharmaceutical research show it is extensive with the pharmacological action of cape jasmine, have liver protection, cholagogue, analgesia, anti-inflammatory, antibacterial, it is antitumor, drop
A variety of pharmacological activity such as blood pressure and blood lipoid are Chinese medicine compositions that is of crucial importance and having very great development utility value.Wherein Cape jasmine
The main active constituent crocin of son, while being also the main active substances of Tibetan medicine west safflower, there is anti-oxidant, anti-artery congee
Sample hardening and the effect for adjusting blood lipid are a kind of unique natural carotenoid pigments of nature, by crocetin
(crocetin) it is combined into two molecule gentiobioses, including crocin-I and crocin-II, warp with higher
Ji value, is widely used in food, medicine and cosmetic field.Some researches show that crocin and crocetin have
Free radical and significant ground antioxidation are removed, and in the pharmacological mechanism of carotenoid, antioxidant activity is especially heavy
It wants, and it has been reported that the resist oxygen lack energy of animal can be improved in the drug with Scavenger of ROS, free radical and antioxidation
Power mitigates hypoxic insult.
Since west safflower yield is extremely low, the market price is higher, and Gardenia Yellow and west safflower it is having the same activity at
Divide crocin, therefore, it is necessary to carry out science to Gardenia Yellow, effectively develop.
Summary of the invention
Technical problem to be solved by the invention is to provide anti-high altitude anoxia anti-fatigue activities in a kind of simple and easy cape jasmine
The separation method of ingredient.
Technical problem to be solved by the invention is to provide the applications of high altitude anoxia anti-fatigue activity ingredient anti-in the cape jasmine.
To solve the above problems, in cape jasmine of the present invention anti-high altitude anoxia anti-fatigue activity ingredient separation method, packet
Include following steps:
(1) after drying, the cape jasmine fruit distillation water boiling and extraction of 20 ~ 40 mesh being crushed to, through filtering, reduced pressure, spray
Mist is dry to get gardenia powder;
(2) the gardenia powder is configured to the aqueous solution of 20 ~ 40 mg/mL with 25 DEG C of distilled water;
(3) by the step, (2) resulting aqueous solution presses 1.0 ~ 3.0 times of column volume with the flow velocity injection of 1.5 ~ 15mL/min
Processed 14 ~ 30 mesh polyamide column of the cm of 8cm × 100, then 1.0 ~ 3.0 times of column volume is pressed with the stream of 5.0 ~ 10.0 mL/min
Speed distilled water flushing polyamide column, respectively obtains polyamide column loading efflux, water elution;
(4) after polyamide loading efflux and water elution being merged, amalgamation liquid with the flow velocity whole injection of 10mL/min at
The macroporous resin column managed, first by 1.0 ~ 3.0 times of column volume with the flow velocity of 5.0 ~ 10.0 mL/min distilled water flushing macropore
Resin column, then press the ethyl alcohol that 2.0 ~ 10.0 times of column volume is 10 ~ 70% with the flow velocity volumetric concentration of 1.5 ~ 10.0 mL/min
Solution rinses macroporous resin column, obtains 10 ~ 70% ethanol eluate, which is concentrated under reduced pressure, is freezed
To get Gardenoside product after drying;
(5) pressing 1.0 ~ 3.0 times of column volume first with the flow velocity volumetric concentration of 5.0 ~ 10.0mL mL/min is 10 ~ 30%
Ethanol solution rinses polyamide column removal of impurities, then by 2.0 ~ 10.0 times of column volume with the flow velocity volume of 1.5 ~ 10.0 mL/min
The ethanol solution that concentration is 30 ~ 90% rinses the polyamide column, obtains 30 ~ 90% ethanol eluate, 30 ~ 90% ethyl alcohol
Eluent be concentrated under reduced pressure, be freeze-dried after to get Gardenia Yellow product.
(1) the middle extraction conditions that decoct refer to that feed liquid mass ratio is 1:8 ~ 10 to the step, and temperature is 90 ~ 100 DEG C, number 2
~ 3 times, each time is 1 hour.
The step is (1), (4) (5) the middle condition being concentrated under reduced pressure each means that temperature is 50 DEG C ~ 80 to the step with the step
℃。
(1) the middle condition being spray-dried refers to that temperature is 120 ~ 140 DEG C to the step, 20 ~ 30 m of unit time intake3,
0.1 ~ 0.4MPa of atomisation pressure.
(4) (5) the middle condition being freeze-dried each means that temperature is -55 DEG C ~ 20 DEG C to the step with the step, and vacuum degree is
0.2MPa~0.5 MPa。
(4) middle macroporous resin column refers to D-101, HPD100, XDA-6, DM-130, DA201 type macroreticular resin to the step
In any one.
The step (3) in processed polyamide column and the step (4) in processed macroporous resin column each mean
The ethanol elution for being first 95% with volumetric concentration, until ethanol eluate adds distilled water muddiness do not occur, then to distill washing
De- pillar to no alcohol taste to get.
The step (3) in processed polyamide column size be the cm of 8cm × 100.
The obtained Gardenia Yellow of separation method of anti-high altitude anoxia anti-fatigue activity ingredient is made in cape jasmine as described above
For the application of Substituted phenyl-lactic acid ingredient in medicine, it is characterised in that: using Gardenia Yellow as active constituent, be equipped with medicinal stone
Any dosage form being prepared into pharmacy;Or using Gardenia Yellow as active constituent, anti-oxidant and/or antifatigue work is added
Property is equipped with any dosage form that pharmaceutic adjuvant is prepared into pharmacy at being grouped as compound.
The dosage form refers to hard capsule, soft capsule, ordinary tablet, sugar coated tablet, Film coated tablets, special-shaped tablets, chewable tablets, effervesce
Piece, dispersible tablet, granule, pill, solution, any one in syrup.
The obtained Gardenia Yellow of separation method of anti-high altitude anoxia anti-fatigue activity ingredient is made in cape jasmine as described above
For application of anti-oxidant, anti-fatigue effect the active constituent in terms of preparing anti-oxidant or anti-fatigue health-product containing.
Compared with the prior art, the present invention has the following advantages:
1, the Gardenia Yellow that extracts of the present invention as Substituted phenyl-lactic acid ingredient drug effect can from following 4 test in body
It is existing:
Test 1 active component of cape jasmine acute toxicity testing
(1) experiment purpose: screening active component of cape jasmine toxic component.
(2) experiment condition: three-level Animal Lab., 20 ~ 25 DEG C of room temperature, air-conditioning constant temperature.
(3) experimental subjects: animal BalB/C mouse 90, half male and half female, 20 ± 2g of weight are always cured by Lanzhou military region Lanzhou
Zoopery section, institute provides, quality certification number: curing dynamic word the 1402-0201st in Gansu Province.
(4) medicinal material and instrument: cape jasmine water extract, cape jasmine polysaccharide, Gardenia Yellow, Gardenoside are made by oneself by laboratory, face use
Before 0.1g/mL aqueous solution is made;4% paraformaldehyde (lot number: 20150727 Beijing Suo Laibao Science and Technology Ltds) sterile injection is used
Water (Kelun Pharm Ind Co., Ltd., Sichuan, lot number: M15111005).
Optical microscopy (Japanese Nikon company, E200);Histotome (German Meikang company, HM340E);TB-
The automatic embedding machine of 718E type biological tissue (Hubei Tai Ya Electron Technology Co., Ltd).
(5) experimental method
1. 50 BALB/C mices (half male and half female) are randomly divided into blank control group, and (0.1mL/10g sterile injection is used
Water), cape jasmine water extract (1.0g.kg-1.d-1), Gardenia Yellow group (1.0g.kg-1.d-1), cape jasmine multiple groups (1.0g.kg-
1.d-1), Gardenoside (1.0g.kg-1.d-1), gastric infusion, continuous 5 days.Observe mouse physiological phenomenon, changes of weight.
2. 40 BALB/C mices (half male and half female) are randomly divided into blank control group, and (0.1mL/10g sterile injection is used
Water), Gardenoside low dose group (0.5g.kg-1.d-1), Gardenoside middle dose group (1.0g.kg-1.d-1), Gardenoside high dose group
(2.0g.kg-1.d-1), continuous 5 days, gastric infusion.Observe mouse physiological phenomenon, changes of weight.Dissection mouse takes half small intestine,
With normal saline flushing it is clean after, the fixed small intestine of 4% paraformaldehyde of 4mL is added in 5mL EP pipe, room temperature does disease afterwards for 24 hours
Reason slice, carries out HE dyeing.
(6) experimental result
Administration Gardenia Yellow group mouse is acted normally, and without any intoxicating phenomenon, has safety.
Gardenoside group mouse is apathetic after administration, slow in action, shows serious phenomenon of having loose bowels, and stool color is deep
Blue, locally there is blue spot in tail, and after administration two days, the phenomena of mortality has occurred in Gardenoside group mouse, after administration three days, Cape jasmine
Sub- glycosides group hero mouse is all dead, and female mice is only survived 1.Cape jasmine water extract group mouse has slight phenomenon of having loose bowels.Cape jasmine water mentions
Object and Gardenoside mouse weight is taken to mitigate, wherein the variation of Gardenoside group mouse weight is obvious.Other groups are all relatively more normal.
Influence of the Gardenoside to mouse small intestine histo pathological change: HE coloration result shows, naive mice small intestine
Structure is normal, and mucous secretion is normal (Figure 1A).Gardenoside low dose group mouse small intestine tissue change is obvious, and mucous secretion is hyperfunction
(Figure 1B).Gardenoside high dose group intestinal mucus secretes more obvious (Fig. 1 C).
(7) discuss
Gardenia Yellow main component is the crocin (crocin) and crocetin (crocetin) of carotenoids, tool
There are the pharmacological actions such as protection cardiac muscle cell, antiatherosclerosis, anti-oxidant, Adjust-blood lipid, anticoagulation and antithrombotic.Above-mentioned experiment
Research finds that Gardenia Yellow does not have toxic side effect, good security.
Gardenoside can promote the wriggling of large intestine, have effects that rush down lower.Cape jasmine water extract and Gardenoside oral administration, to dynamic
Object has significant discharge function.Above-mentioned the experimental results showed that Gardenoside has toxicity, and toxicity is quite obvious, and cape jasmine water extracts
Part Gardenoside can be contained in object, so mouse can also show phenomenon of slightly having loose bowels, and Gardenoside group mouse phenomenon of having loose bowels is tight
Weight, intestinal mucus secretion increase, and changes of weight is obvious, and the death rate is high, has serious toxicity.
Test the antioxidation activity in vitro test of 2 cape jasmine the different extracted parts
(1) experiment purpose: the oxidation-resistant active ingredient of antioxidation in vitro experiment screening cape jasmine is passed through.
(2) reagent and instrument:
1. medicinal material and reagent
Cape jasmine is purchased from Lanzhou the Yellow River Chinese Medicinal Materials Markets, all identifies through the Gansu university of TCM director Yang Xicang pharmacist of traditional Chinese medicine
For madder wort cape jasmine (Gardenia jasminoides Ellis dry mature fruit);1,1- diphenyl -2-, three nitre
Base phenylhydrazine (DPPH, Solarbio company, lot number 101029108), 2,2- connection nitrogen bases-it is bis--(3- ethyl benzo thiazole phenanthroline-
6- sulfonic acid) two ammonia salts (ABTS, Solarbio company, lot number 20151104), TRIS(Solarbio company, lot number 77861),
Ascorbic acid (VC, Solarbio company, lot number 50817), pyrogallic acid (Solarbio company, lot number
20151202), 1,10- ferrosin (Solarbio company, lot number 20150916), ethylenediamine tetra-acetic acid (EDTA, Aladdin
Company, lot number 46631);Sodium nitroprusside, aluminum nitrate, sodium hydroxide, sodium nitrite, the potassium ferricyanide, sodium dihydrogen phosphate,
Ammonium molybdate, ferrous sulfate, sulfuric acid, thiobarbituricacidα-, lecithin, sodium thiosulfate, potassium iodide, 30% hydrogen peroxide, tri-chlorination
Iron, disodium ethylene diamine tetraacetate, trichloroacetic acid, sodium phosphate, potassium peroxydisulfate, glacial acetic acid etc. are ommercially available AR;
2. instrument
3K15 type high speed freezing centrifuge (Sigma Co., USA);The full-automatic luciferase mark of SpectraMax i3 type
Instrument (Molecular Devices company, the U.S.);WD-9403F type ultraviolet-visible spectrophotometer (hewlette-packard);
BP210S type electronic balance (German Sartorius company);(the upper macro experimental facilities of Nereid is limited for DK-8A type electric heating constant temperature sink
Company);Freeze drier (Spain's Telster LyoQuest-55 plus type).20 ~ 25 DEG C of experimental temperature, air-conditioning is permanent
Temperature, relative humidity: 40% ~ 70%.
(3) experimental method
1. DPPH radicals scavenging is tested
According to document, by the sample and V of different quality concentration (0.03 ~ 0.5mg/mL)C125 μ L of solution, is separately added into 125
In 95% ethanol solution of μ L 0.1mmol/L DPPH, dark at room temperature reacts 30min, does blank control with 95% alcohol solvent,
Measure its absorbance (A at wavelength 517nmi);It measures 125 μ L DPPH, 95% ethanol solution and 125 μ L, 95% ethyl alcohol is mixed
Absorbance (A after conjunction at wave 517nm0);125 μ L, 95% ethanol solution and 125 μ L sample solution are measured in wavelength 517nm
Absorbance (the A at placej).Its clearance rate is calculated by formula (1), and calculates its EC50。
Clearance rate (%)=(1- (Ai- Aj) /A0) × 100
2. ABTS radicals scavenging is tested
Isometric 7mmol/L ABTS solution is mixed to be allowed to react with 2.45mmol/L potassium peroxydisulfate and is placed in dark place
12~16h prepares ABTS free radical.ABTS free-atom aqueous solution, which is diluted to its absorbance at wavelength 734nm, with 95% ethyl alcohol is
0.70± 0.02.By 100 μ L different quality concentration (0.08~2.0mg/mL) samples and VC It is free that 3.9mL ABTS is added in solution
In based sols, it is placed at room temperature for 10min, measures its absorbance (A at wavelength 734nmi);It is molten to measure 3.9mL ABTS free radical
Absorbance (A at wavelength 734nm after liquid is mixed with 100 μ L95% ethyl alcohol0);Measure 95% ethanol solution of 3.9mL and 100 μ L
Absorbance (A of the sample solution at wavelength 734nmj).Its clearance rate is calculated by formula (1), and calculates its EC50。
3. hydroxyl radical free radical clearance test
Take 0.75 mmol/L Phen, 1.0 mL, the phosphate buffer solution 2.0mL, 40 μ g/mL of pH=7.4
, 0.75 mmol/L FeSO41.0 mL, the sample solution 1.0mL, 0.01% H of different quality concentration2O21. 0 mL is (new
Fresh preparation), absorbance A is measured at 520 nm after reacting 60 min after mixing in 37 DEG C of water-bathss.Blank group is with 1.0 mL
Distilled water replaces sample to measure absorbance A0, control group is with 1.0mL distilled water instead of H2O2Optical density A is measured with samplec,
It is returned to zero with 4.0mL distilled water and 2.0mL phosphate buffer solution.Its clearance rate is calculated by formula (2), and calculates its EC50。
Clearance rate (%)=(As-A0)/(Ac- A0)
4. anti peroxidation of lipid is tested
300 mg lecithin are dissolved in the phosphate buffer solution of 30 mL 10 mmol/L, pH=7.40, ice bath shake
It swings, lecithin soln is made.0.20 mL of lecithin soln is taken, 1.0 mL of phosphate buffer solution of pH 7.40 is added, it is different dense
Spend (0.08~2.0mg/mL) sample solution 0.50 mL, 2.5 mmol/(II) 1.0 mL of L EDTA-Fe, after mixing in
45 min are reacted in 37 DEG C of water-baths, add trichloroacetic acid 2.0 mL of 28% (m/V), thio bar of 1% (m/V)
Than appropriate sour 1.0 mL, mixing, which is placed in 100 DEG C of boiling water baths, heats 10 min, and absorbance A is measured at 523nm after coolingSample,
It is returned to zero with phosphate buffer, the effective phosphate buffer of blank replaces sample densitometric A0.It is calculated according to formula (3) corresponding
Inhibiting rate and and VcIt is compared.
Inhibiting rate (%)=(A0- ASample)/A0
5. the measurement of total reducing power
By sample solution (0.25~10.0 mg/mL) 1.0 mL of different quality concentration, be added 2.5 mL pH=
6.6 phosphate buffer, the potassium ferricyanide solution of 2.5 mL 1%, obtains mixed solution, is placed in 50 DEG C of water-baths and keeps the temperature 20 min,
2. 5 mL10% solution of trichloroacetic acid are added, gained mixed solution is centrifuged (3 000 rmin-1,10 min), inclines and takes
Clear liquid, precision draw 2.5 mL, and the liquor ferri trichloridi of 2.5 mL distilled water and 0.5 mL 0.1% is added, and examine at 700 nm
Survey absorbance A and and VcIt is compared.
6. the measurement of total antioxidant capacity
By sample solution (0.08~2.0 mg/mL) 0. 1 mL of different quality concentration, 1.0 mL reagent solutions are added
(including the sulfuric acid of 0.6mol/L, the sodium phosphate of 28 mmol/L, the ammonium molybdate of 4mmol/L in reagent solution).Mixed liquor is placed in
95 DEG C of water-baths are incubated for 90 min.It lets cool to room temperature, absorbance A and and V is surveyed using distilled water as blank, at 695 nm of Yu BochangcInto
Row compares.
(4) cape jasmine the different extracted parts antioxidation in vitro result
1. scavenging effect of the cape jasmine the different extracted parts to DPPH free radical
As shown in Figure 2, there are notable difference, Vc, Cape jasmine for Scavenging activity of the different extracted parts of cape jasmine to DPPH free radical
Sub- uranidin and cape jasmine crude extract have the apparent ability for removing free radical.Wherein, Vc and Gardenia Yellow are to DPPH freedom
The scavenging effect of base is significant, and with the increase of concentration, Gardenia Yellow enhances the scavenging effect of DPPH free radical,
It is in apparent dose-effect relationship in 0.03-0.5mg/mL concentration range, Gardenia Yellow is calculated to the IC of DPPH free radical50For
0.188 mg/mL.Gardenoside and polysaccharide are suitable to the Scavenging activity of DPPH free radical, and activity is smaller.
2. scavenging effect of the cape jasmine the different extracted parts to ABTS free radical
From the figure 3, it may be seen that there are notable difference, Vc, Cape jasmine for Scavenging activity of the different extracted parts of cape jasmine to ABTS free radical
Sub- uranidin and cape jasmine crude extract have the apparent ability for removing free radical.Wherein, Vc and Gardenia Yellow are to ABTS freedom
The scavenging effect of base is significant, and the Scavenging activity of Vc is significantly higher than each extract of cape jasmine.And with the increase of concentration, Vc, Gardenia Yellow
Pigment and cape jasmine crude extract enhance the scavenging effect of ABTS free radical, in apparent in 0.08~2.0mg/mL concentration range
Vc, Gardenia Yellow is calculated to the IC of ABTS free radical in dose-effect relationship50Respectively 0.078 mg/mL, 0.510 mg/mL.
Gardenoside and saccharide portion are weaker to the Scavenging activity of ABTS free radical, and with the no significant changes of the increase of concentration.
3. scavenging effect of the cape jasmine the different extracted parts to hydroxyl radical free radical
As shown in Figure 4, the different extracted parts of cape jasmine show the different degrees of Scavenging activity to hydroxyl radical free radical,
Vc, Gardenia Yellow and cape jasmine crude extract have the apparent ability for removing hydroxyl radical free radical.Wherein, Gardenia Yellow and cape jasmine
Crude extract has apparent scavenging effect to hydroxyl radical free radical, and the Scavenging activity of Vc is significantly higher than each extract of cape jasmine.And with dense
The increase of degree, Gardenia Yellow and cape jasmine crude extract enhance the scavenging effect of hydroxyl radical free radical, dense in 0.09~0.5mg/mL
Spending in range is in apparent dose-effect relationship, and Gardenia Yellow and cape jasmine crude extract is calculated to the IC of hydroxyl radical free radical50Respectively
For 0.198mg/mL, 0.327mg/mL.Gardenoside and saccharide portion are weaker to the Scavenging activity of hydroxyl radical free radical, and with dense
The no significant changes of the increase of degree.
4. cape jasmine the different extracted parts are to the inhibiting effect of lipid peroxidation
As shown in Figure 5, the different extracted parts of cape jasmine show the ability of different degrees of anti peroxidation of lipid, in phase
With in 0.08~2.0mg/mL of concentration range, the anti peroxidation of lipid ability of Gardenia Yellow is most strong and is apparently higher than cape jasmine and slightly mentions
Object, and with the increase of concentration, anti peroxidation of lipid ability gradually increases.Gardenoside and the anti-oxidant energy of the lipid of polysaccharide component
Power is most weak and is significantly lower than Gardenia Yellow and cape jasmine crude extract, and when concentration increases, the anti peroxidation of lipid ability of the two is with dense
Degree increases no significant change.
5. the measurement of the total reducing power of cape jasmine the different extracted parts
The reducing power of each substance has reacted its antioxidant activity to a certain extent, the potassium ferricyanide by antioxidant also
Original has maximum absorption band at the substance that potassium ferrocyanide, potassium ferrocyanide and ferric ion generate at 700nm.Absorbance is got over
The reducing power of big substance is stronger.Such as Fig. 6, in 0.25~10.0 mg/mL of same concentrations range, each extract part of cape jasmine with
The increase absorbance of concentration improves, wherein the absorbance value of Gardenia Yellow and cape jasmine crude extract is obvious with the increase of concentration
Increase, Gardenia Yellow is especially pronounced, close with Vc effect trend.
6. the measurement of cape jasmine the different extracted parts total antioxidant capacity
Such as Fig. 7, each extract part of cape jasmine and Vc are measured at 695nm in 0.08~2.0 mg/mL of same concentrations range
The absorbance that total antioxidant capacity obtains is increased with the increase of concentration.Wherein, the effect trend comparison of Gardenia Yellow is bright
Aobvious, the absorbance value of Gardenoside and polysaccharide component hardly changes with the increase of concentration.
(5) conclusion:
This experiment to each extract of cape jasmine remove in vitro DPPH free radical, ABTS free radical, hydroxyl radical free radical ability and
Lipid peroxidation rejection ability, total reducing power, total antioxidant capacity are studied, the results showed that, each extract pair of cape jasmine
DPPH free radical, ABTS free radical, hydroxyl radical free radical and lipid peroxidation rejection ability, total reducing power, total antioxidant capacity
Certain oxidation resistance is shown, and correlation is almost the same, wherein Gardenia Yellow is free to DPPH free radical, ABTS
The IC of base, hydroxyl radical free radical50Respectively 0.188 mg/mL, 0.510 mg/mL, 0.198mg/mL, and there is certain lipid
Peroxidating rejection ability, reducing power and total antioxidant capacity, within the scope of a certain concentration, with the increasing of Gardenia Yellow concentration
Add, antioxidant activity enhancing.Therefore Gardenia Yellow can effectively remove free radical, have good antioxygen also ability.
Test the experiment of 3 mouse atmospheric closeds
(1) experiment purpose: mouse atmospheric closed experiment screening active component of cape jasmine Substituted phenyl-lactic acid ingredient is passed through.
(2) experiment condition: three-level Animal Lab., 20~25 DEG C of room temperature, air-conditioning constant temperature.
(3) experimental subjects: animal BalB/C mouse 60,20 ± 2g of weight, real by Lanzhou General Hospital of Lanzhou Military Command animal
Section's offer is tested, quality certification number: curing dynamic word the 1402-0201st in Gansu Province.
(4) medicinal material and instrument: cape jasmine water extract, cape jasmine polysaccharide, Gardenia Yellow, Gardenoside are made by oneself by laboratory, face use
Before 0.05g/mL aqueous solution is made.Rhodiola rosea capsules (Chinese People's Liberation Army, root of kirilow rhodiola development center, Tibet Military Area Command, lot number:
130604) 0.05g/mL is made before use.Sterilized water for injection (Kelun Pharm Ind Co., Ltd., Sichuan, lot number:
M15111005).
Electric drying oven with forced convection (101A, Shanghai laboratory apparatus factory);(German Sartorius is public for BP210S electronic balance
Department).
(5) experimental method
1. 60 BALB/C mices (half male and half female) are randomly divided into blank control group (0.1mL/10g distilled water), red scape
Its group (0.5g.kg-1.d-1) cape jasmine ethanol extract group (0.5g.kg-1.d-1), Gardenia Yellow group (0.5g.kg-1.d-1), Cape jasmine
Sub- polysaccharide group (0.5g.kg-1.d-1), Gardenoside group (0.5g.kg-1.d-1), gastric infusion, continuous 5 days.It will after last dose 1h
Mouse is put into the 200 mL ground wide-mouth bottles for filling 5 g soda limes (absorbing carbon dioxide and water), and every bottle puts 1 mouse, and
And bottleneck is smeared with vaseline, covering tightly prevents gas leakage, immediately timing.It is with mouse breathing stopping (the mouse chest does not rise and fall) time
Index observes the mouse time dead due to anoxic.
2. 60 BALB/C mices (half male and half female) are randomly divided into blank control group (0.1mL/10g distilled water), model
Group (0.1mL/10g distilled water), root of kirilow rhodiola group (1.0g.kg-1.d-1), Gardenia Yellow low dose group ((0.25g.kg-1.d-1),
Gardenia Yellow middle dose group ((0.5g.kg-1.d-1), Gardenia Yellow high dose group (1.0g.kg-1.d-1), gastric infusion, even
It is 5 days continuous.Mouse is put into after last dose 1h in the 200 mL ground wide-mouth bottles for filling 5 g soda limes, every bottle puts 1 mouse,
Bottleneck is smeared with vaseline, covering tightly prevents gas leakage, immediately timing.Stop (the mouse chest does not rise and fall) time with mouse breathing to refer to
Mark observes the mouse time dead due to anoxic.Take brain tissue and lung tissue to measure wet quality, and with 55 DEG C of electric heating forced air dryings
It is 3 days dry in case, the dry mass of brain tissue and lung tissue is surveyed, is calculated by formula (wet mass-dry mass)/wet quality × 100
Brain lung tissue water content.
(6) experimental result
1. influence of the active component of cape jasmine to the atmospheric closed mouse anti anoxia time is compared with blank group (NG), when anti anoxia
Between increase, Gardenia Yellow group (Crocin) mouse anti anoxia time obviously increases (P < 0.01).With positive drug root of kirilow rhodiola group
(Rhodiola) compare, Gardenia Yellow group (crocin) mouse anti anoxia time obviously increases.It the results are shown in Table 1:
The 1 active component of cape jasmine each group mouse atmospheric closed anti anoxia time of table (, n=10)
Tab. 1 The time of mice sustaining anoxia at common atmosphere in
Each group of the effective-part of Gardenia(,n=10)
Note: p < 0.01 * p < 0.05, * *, administration group vs blank group.
Note: *p<0.05,**p<0.01,medicated group compared with NG
2. low middle each dosage group of height (Crocin-L, Crocin-M, Crocin-H) the mouse atmospheric closed of Gardenia Yellow is anti-
Hypoxic exposure increased compared with model group, when Gardenia Yellow high dose group (Crocin-H) is with model group (MG) anti anoxia
Between compared to have conspicuousness (P < 0.05).It the results are shown in Table 2:
The 2 Gardenia Yellow each group mouse atmospheric closed anti anoxia time of table (,n=10)
Tab. 2 The time of mice sustaining anoxia at common atmosphere in
each group of crocin
(,n=10)
Note: p < 0.01 * p < 0.05, * *, administration group vs model group.
Note:Note: *p<0.05,**p<0.01,medicated group compared with NG
3. influence of the Gardenia Yellow (Crocin) to mouse lung tissue and brain water content: compared with blank group, mould
Type group (MG) mouse lung tissue water content obviously increases (P < 0.01), and brain water content also obviously increases (P < 0.05).Red scape
Its group (Rhodiola) and low middle high each group (Crocin-L, Crocin-M, the Crocin-H) mouse lung tissue of Gardenia Yellow and
Brain water content significantly reduces (P < 0.05 or P < 0.01) compared with model group, without significant change compared with blank group (NG).
It the results are shown in Table 3:
3 Gardenia Yellow of table to mouse lung tissue and brain water content influence (,n=10)
Tab. 3 Effect of Crocin on the water content of lung and brain in
mice (x±s, n=10)
Note: **P < 0.01,*0.05 model group vs blank control group of P <;## P < 0.01,# P < 0.05, administration group vs
Model group.
Note: **P < 0.01,*P < 0.05, MG compared with NG group;## P < 0.01,# P < 0.05,
medicated group compared with NG group
(7) discuss
Tissue ischemia anoxic is mainly shown as that cellular oxidation process obstacle, energy generate insufficient, anaerobic metabolism product accumulation
, cell functional disorders, even eucaryotic cell structure change.Normobaric hypoxia is non-specific anoxic, and mouse is in closed container by anoxic
Factor damage, is mainly reflected in the heart and cerebral anoxia.Studies have reported that reduce acute hypoxic rat dead for trans-crocetin sodium salt
Rate is died, shows that crocetin can be improved the hypoxia-bearing capability of animal.Root of kirilow rhodiola plays the role of anti anoxia, can significantly improve small
The hypoxia-bearing capability of mouse cardiac muscle.This experiment studies Gardenia Yellow (Crocin) Substituted phenyl-lactic acid using root of kirilow rhodiola as positive drug,
The result shows that: Gardenia Yellow (Crocin) has significant extension to act on the time-to-live of mouse normobaric hypoxia condition.Anoxic
Pulmonary arterial pressure is caused to increase the change with haemodynamics;Inflammatory mediator will lead to impaired vascular endothelium, and permeability increases, largely
Liquid enters interstitial lung, and the liquid for entering interstitial lung can enter alveolar after cannot being efficiently absorbed, to form alveolar lung
Oedema.Anoxic can cause blood-brain barrier (BBB) permeability to increase, and BBB permeability increases and can should send out vascular brain edema.This
Experimental studies have found that Gardenia Yellow (Crocin) can significantly mitigate atmospheric closed mouse lung tissue and brain water content, it can
Mitigate brain edema and pulmonary edema.
It tests mouse power under 4 hypobaric hypoxia environments and exhausts swimming test
(1) experiment purpose: the anti-fatigue active that simulation hypobaric hypoxia environment studies Gardenia Yellow is passed through.
(2) experiment condition: three-level Animal Lab., 20~25 DEG C of room temperature, air-conditioning constant temperature, relative humidity: 40%~70%.
(3) experimental subjects: animal BalB/C mouse 60,20 ± 2g of weight, real by Lanzhou General Hospital of Lanzhou Military Command animal
Section's offer is tested, quality certification number: curing dynamic word the 1402-0201st in Gansu Province.
(4) reagent and instrument:
1. reagent: Rhodiola rosea capsules (Chinese People's Liberation Army, root of kirilow rhodiola development center, Tibet Military Area Command, lot number: 130604);
Macroporous absorbent resin (the net product type of D101, Tianjin sea light Chemical Co., Ltd., lot number: 070305);75% ethyl alcohol (Shandong benefit
Er Kang sterilizes Science and Technology Co., Ltd., lot number: 130619);CK testing cassete (product batch number: 20151201), liver/muscle glycogen examination
Agent box (product batch number: 20151202), ultramicron ATP (Na+K+) testing cassete (product batch number: 20151203), ultramicron ATP
(product batch number: Ca2+Mg2+), testing cassete (product batch number: 20151203), succinate dehydrogenase (product batch number: SDH) test
Box (20151203), pyruvate kinase (PK) kit (product batch number: 20151203), malonaldehyde (product batch number: MDA) test
Box (20151202), reduced glutathione (GSH) kit (product batch number: 20151203), pyruvate reagent box (production
Lot number: 20151203), Coomassie brilliant blue (product batch number: 20151218), SOD kit (survey total) (product batch number:
20151130), BCA assay kit (product batch number: 20151203), lactic dehydrogenase (LDH) testing cassete (product batch number:
20151006), lactic acid (LD) testing cassete (product batch number: 20151014) builds up biotechnology research institute by Nanjing and provides;10
× PBS(lot number: 20140807) it is purchased from Beijing Suo Laibao Science and Technology Ltd.Electric drying oven with forced convection (101A, Shanghai experiment instrument
Device factory);BP210S electronic balance (German Sartorius company).
2. instrument: DYC-9070 type simulated high altitude hypobaric hypoxia animal experimental chamber (Guizhou wind and thunder aerial armament Limited Liability
Company);3K15 type high speed freezing centrifuge (Sigma Co., USA);The full-automatic luciferase mark of SpectraMax i3 type
Instrument (Molecular Devices company, the U.S.);Animal's whole blood cytoanalyze (XT-2000i, Japanese Sysmex);
WD-9403F type ultraviolet-visible spectrophotometer (hewlette-packard);BP210S type electronic balance (German Sartorius
Company);DK-8A type electric heating constant temperature sink (the upper macro experimental facilities Co., Ltd of Nereid);TB-718E type biological tissue wraps automatically
Bury machine (Hubei Tai Ya Electron Technology Co., Ltd);E200 type optical microscopy (Japanese Nikon company);HM340E type group
Knit slicer (German Meikang company);Electric homogenizer (Polytron@PT 1200E, Kinematica AG company), it is cold
Lyophilizer (Spain's Telster LyoQuest-55 plus type).
(5) experimental method
1. mouse swimming time detects
72 BALB/C mices, are randomly divided into 6 groups, i.e., normal oxygen control group, model group, Rhodiola rosea capsules positive controls and
Gardenia Yellow low, middle and high dose groups, every group 12.Normal oxygen control group and model group stomach-filling sterilized water for injection (0.2mL/
20g), corresponding reagent is given in stomach-filling to remaining each group respectively.Remaining each group is placed in large-scale low-pressure oxygen cabin in addition to normal oxygen control group
8000 m altitude environment of altitude simulating (in cabin pressure: 35.9 kPa, partial pressure of oxygen: 7.4 kPa), every morning 9:00 is with 10 m
s-1Flow velocity drops to pressure in 4000 cabins m(: 62.1 kPa, partial pressure of oxygen: 13.8 kPa), experimenter is into cabin, the stomach-filling in cabin
Water food and padding, continuous 5 d, after daily administration, by cabin inner height with 10 m s are changed in administration-1Flow velocity at the uniform velocity rise to
Predetermined 8000 m of elevation, animal freely ingests and intakes during this period.Normal oxygen control rats are raised simultaneously in animal house.Last
After 1 h is administered, is tested in 4000 m of height above sea level, lain at 1/3 tail with the load (galvanized wire) of mouse weight 7%, be put into the depth of water 18
In the sink (cm × 30 of 50 cm × 40 cm) of cm, water temperature control carries out swimming with a load attached to the body in (25 ± 1) DEG C, and record mouse is from putting
Enter sink to mouse and sink to 7 s of water to fail the time to float on the surface, as mouse swimming time.
2. mice serum level detects
It after power exhausts swimming, takes out immediately, plucks eyeball and take blood, 3500 r/min are centrifuged 10 min after standing 1 h, isolated
Serum.
3. blood routine
20 μ l EDTA anticoagulations are taken, after 180 μ l blood dilution liquids are added, are detected on animal's whole blood cytoanalyze
Routine blood indexes.
4. mouse muscle and hepatic tissue Activity determination
After cervical dislocation is put to death, the quadriceps muscle of thigh and liver of two hind legs are taken, is cleaned and is dried with ice physiological saline, weigh 140-
10% homogenate is made in 150mg tissue, cold PBS, and 3500 r/min are centrifuged 10 min, take supernatant.
5. statistical procedures
Statistical procedures are carried out using 17.0 statistical software of SPSS.As a result withIt indicates, comparison among groups use variance
Analysis and t are examined.It is that difference is statistically significant with P < 0.05.
(6) results of animal
1. each group mouse swimming power exhausts time detection
Compared with normal oxygen control group, Rhodiola rosea capsules group and Gardenia Yellow low, middle and high dose groups can significantly extend small
Mouse swimming time, difference have statistical significance (P < 0.01 or P < 0.05).Each group mouse swimming time is shown in Table
4。
4 mouse swimming time result of table (,n=12)
Note: **P < 0.01,*0.05 model group vs blank control group of P <;## P < 0.01,# P < 0.05, model group vs
Administration group.
2. each group mouse metabolism product detection, compared with normal oxygen group, the content of anoxia model group mouse blood urea nitrogen is significant
Raising, difference have statistical significance (P < 0.05).Rhodiola rosea capsules group and Gardenia Yellow compared with anoxia model group
High, middle dose group can significantly reduce the content of blood urea nitrogen, and difference has statistical significance (P < 0.05);Compared with normal oxygen group,
Acetone acid content in model group mouse liver, muscle and serum significantly reduces, and difference has statistical significance (P < 0.05).
Compared with anoxia model group, Rhodiola rosea capsules group and Gardenia Yellow high dose group can significantly improve liver, muscle and serum
The content of middle pyruvic acid, Gardenia Yellow middle dose group can also improve the content of pyruvic acid in serum, and difference is anticipated with statistics
Adopted (P < 0.05);Compared with normal oxygen group, lactic acid content is significantly increased in anoxia model group mouse liver, muscle and serum, difference
With statistical significance (P < 0.01 or P < 0.05).Compared with anoxia model group, Rhodiola rosea capsules group and Gardenia Yellow are high
Dosage group can significantly reduce mouse liver, lactic acid content in muscle and serum, and difference has statistical significance (P < 0.01 or P <
0.05) in Gardenia Yellow, low dose group can also reduce the content of lactic acid in serum, and difference has statistical significance (P <
0.01).Each group mouse liver, muscle, the testing result of BUN, pyruvic acid and LD are shown in Table 5 in serum:
5 each group mouse liver of table, muscle, in serum BUN, pyruvic acid and LD detection (,n=12)
Note: **P < 0.01,*0.05 model group vs blank control group of P <;## P < 0.01,# P < 0.05, model group vs
Administration group.
3. each group mouse oxidation index detects compared with normal oxygen group, GSH is significant in anoxia model group mouse liver, muscle
It reduces, difference has statistical significance (P < 0.01 or P < 0.05).Compared with anoxia model group, Rhodiola rosea capsules group and cape jasmine
Uranidin high dose group can significantly improve GSH content, and difference has statistical significance (P < 0.01 or P < 0.05), Gardenia Yellow
Pigment middle dose group can also improve the content of GSH in liver, and difference has statistical significance (P < 0.05);Compared with normal oxygen group,
MDA content significantly increases in anoxia model group mouse liver, muscle, and difference has statistical significance (P < 0.01).With anoxic mould
Type group compares, and Rhodiola rosea capsules group and the middle and high dosage group of Gardenia Yellow can significantly reduce in mouse liver and musculature
MDA content, difference have statistical significance (P < 0.01 or P < 0.05);Compared with normal oxygen group, anoxia model group mouse liver,
SOD activity significantly reduces in muscle and serum, and difference has statistical significance (P < 0.01).Compared with anoxic group, root of kirilow rhodiola glue
Wafer Gardenia Yellow high dose group can significantly improve mouse liver, SOD activity in muscle and serum, and difference has statistics
Meaning (P < 0.01 or P < 0.05), and in Gardenia Yellow, low dose group can also improve the content of SOD in liver and muscle,
Difference has statistical significance (P < 0.01 or P < 0.05).Each group mouse liver, muscle, GSH, MDA, SOD inspection in serum
Survey the results are shown in Table 6.
6 each group mouse liver of table, muscle, GSH, MDA, SOD testing result in serum
Note: **P < 0.01,*0.05 model group vs blank control group of P <;## P < 0.01,# P < 0.05, model group vs
Administration group.
4. each group mouse metabolism adjusts enzyme detection
Compared with normal oxygen group, anoxia model group mouse liver, muscle, LDH activity weakens in serum, and difference has statistics
Meaning (P < 0.01 or P < 0.05);Compared with anoxia model group, Rhodiola rosea capsules group and Gardenia Yellow group high dose group are small
Mouse liver, muscle, LDH activity enhancing in serum, difference is statistically significant (P < 0.01 or P < 0.05), in Gardenia Yellow
Dosage group can also improve the content of LDH in serum, and difference has statistical significance (P < 0.01).Each group mouse liver, muscle,
LDH testing result is shown in Table 7 in serum.
7 each group mouse liver of table, muscle, LDH testing result in serum
Note: **P < 0.01,*0.05 model group vs blank control group of P <;## P < 0.01,# P < 0.05, model group vs
Administration group.
5. each group mouse Energy Metabolism Enzyme detects
Compared with normal oxygen group, in anoxia model group mouse liver, muscle and serum MDH, SDH, PK, Ca-Mg-ATP enzyme and
Na-K-ATP enzymatic activity significantly reduces, and difference has statistical significance (P < 0.01).Compared with anoxia model group, root of kirilow rhodiola glue
Capsule group and the middle and high dosage group of Gardenia Yellow can significantly enhance in Muscle Tissue MDH, SDH, PK, Ca-Mg-ATP enzyme and
Na-K-ATP enzymatic activity, difference have statistical significance (P < 0.01 or P < 0.05), and Gardenia Yellow low dose group can also mention
SDH in high muscle, Na-K-ATP enzymatic activity, difference have statistical significance (P < 0.01) in PK and liver in serum.As a result see
Table 8, table 9:
8 each group mouse liver of table, muscle, MDH, SDH, PK, Ca-Mg-ATP enzyme and Na-K-ATP enzyme detection knot in serum
Fruit
Note: **P < 0.01,*0.05 model group vs blank control group of P <;## P < 0.01,# P < 0.05, model group vs
Administration group.
9 each group mouse Ca-Mg-ATP enzyme of table, Na-K-ATP and CK enzyme testing result
Note: **P < 0.01,*0.05 model group vs blank control group of P <;## P < 0.01,# P < 0.05, model group vs
Administration group.
6. each group mouse ergastic substances detect
Compared with normal oxygen group, anoxia model group Glycogen content is significantly reduced, and difference has statistical significance (P <
0.01 or P < 0.05).Compared with anoxia model group, Rhodiola rosea capsules group and each dosage group of Gardenia Yellow can dramatically increase sugar
Former storage level, difference have statistical significance (P < 0.01 or P < 0.05).Each group Glycogen testing result is shown in Table 10.
10 each group Glycogen testing result of table
Note: **P < 0.01,*0.05 model group vs blank control group of P <;## P < 0.01,# P < 0.05, model group vs
Administration group.
(7) discuss:
The result shows that Gardenia Yellow has good antifatigue effect.Lactic dehydrogenase can be enhanced in Gardenia Yellow
Vigor, reduce lactic acid accumulation, reduce the concentration of BUN, it is seen that Gardenia Yellow can reduce muscle tissue damage, to reduce
The consumption of energy substance, delay fatigue;Evaluation index of the hepatic glycogen amount of storage as internal energy substance, Gardenia Yellow can
Body development and liver glycogen are horizontal by increasing, and when movement increases the release of ATP, promote energetic supersession;By reducing because acutely
The damage of membrane structure caused by moving, reduces CK enzymatic activity, maintains homeostasis, and then increase exercise intensity and run duration,
Realize its anti-sports fatigue effect;SOD is widely present in body cell, can remove the excessive super oxygen yin that generates in vivo from
Sub- free radical, protects DNA, protein and cell membrane from the destruction of superoxide radical, and MDA can directly reflect free radical water
Flat, content height is the important symbol of tissue cell insult, it is known that Gardenia Yellow is removing free radical, anti-oxidant aspect
Significant effect, to achieve the effect that antifatigue;The active variation of SDH can reflect cellular energy metabolism situation, Gardenia Yellow
SDH and MDH activity can be enhanced, promote body aerobic oxidation metabolism;PK is the rate-limiting enzyme of glycolytic pathway, in glycolysis process
In play decisive role, Gardenia Yellow can increase PK content, promote glycolysis, increase ATP, to reach antifatigue effect
Fruit.
2, the present invention can efficiently separate enrichment gardenia yellow pigment with high color value, at the same also by Gardenoside carried out enrichment and it is pure
Change, to improve the utilization rate of medicinal material, for by Gardenia Yellow science, effectively develop, and then is applied to sport nutrition and eats
It lays a good foundation in product field.
3, the invention is simple and feasible, easy to operate, safe, reproducible, can industrialized production.
Detailed description of the invention
Specific embodiments of the present invention will be described in further detail with reference to the accompanying drawing.
Fig. 1 is mouse small intestine pathological section figure of the invention.
Fig. 2 is clearance rate of the cape jasmine the different extracted parts of the present invention to DPPH free radical.
Fig. 3 is clearance rate of the cape jasmine the different extracted parts of the present invention to ABTS free radical.
Fig. 4 is clearance rate of the cape jasmine the different extracted parts of the present invention to hydroxyl radical free radical.
Fig. 5 is the lipid oxidation resistance of cape jasmine the different extracted parts of the present invention.
Fig. 6 is total reducing power of cape jasmine the different extracted parts of the present invention.
Fig. 7 is the total antioxidant capacity of cape jasmine the different extracted parts of the present invention.
Specific embodiment
The separation method of anti-high altitude anoxia anti-fatigue activity ingredient in 1 cape jasmine of embodiment, comprising the following steps:
Will drying, be crushed to the cape jasmine fruits of 20 mesh distillation water boiling and extraction after, through filtering, reduceds pressure, be sprayed
Drying is to get gardenia powder.
Wherein: decocting extraction conditions and refer to that feed liquid mass ratio (g/g) is 1:8, temperature is 90 DEG C, and number is 2 times, when each
Between be 1 hour.
The dry part of the item of reduced pressure refers to that temperature is 50 DEG C.
The condition of spray drying refers to that temperature is 120 DEG C, 20 m of unit time intake3, atomisation pressure 0.1MPa.
(2) gardenia powder is configured to the aqueous solution of 20 mg/mL with 25 DEG C of distilled water.
(3) by step, (2) resulting aqueous solution presses 1.0 times of column volume with the flow velocity injection processed 14 of 1.5mL/min
Mesh polyamide column, then the column volume for pressing 1.0 times are respectively obtained poly- with the flow velocity of 5.0 mL/min distilled water flushing polyamide column
Amide column loading efflux, water elution.
Wherein: processed polyamide column refer to by having a size of 8cm × polyamide column of 100 cm is first with volumetric concentration
95% ethanol elution, until ethanol eluate adds distilled water muddiness do not occur, then to distill water elution pillar to no alcohol
Taste to get.
(4) after polyamide loading efflux and water elution being merged, amalgamation liquid with the flow velocity whole injection of 10mL/min at
The macroporous resin column managed, first by 1.0 times of column volume with the flow velocity of 5.0 mL/min distilled water flushing macroporous resin column, then
Macroporous resin column is rinsed with the ethanol solution that the flow velocity volumetric concentration of 1.5 mL/min is 30% by 2.0 times of column volume, is obtained
30% ethanol eluate, 30% ethanol eluate be concentrated under reduced pressure, be freeze-dried after to get Gardenoside product.
Wherein: macroporous resin column refers to D-101 type macroreticular resin.
The condition of reduced pressure refers to that temperature is 50 DEG C.
The condition of freeze-drying refers to that temperature is -55 DEG C, vacuum degree 0.5MPa.
Processed macroporous resin column refers to the ethanol elution for first using macroreticular resin volumetric concentration to be 95%, until ethyl alcohol
Until eluent adds distilled water muddiness do not occur, then with distill water elution pillar to no alcohol taste to get.
(5) first rinsed by 1.0 times of column volume with the ethanol solution that the flow velocity volumetric concentration of 5.0mL mL/min is 10%
Polyamide column removal of impurities, then rinsed by 2.0 times of column volume with the ethanol solution that the flow velocity volumetric concentration of 1.5 mL/min is 75%
The polyamide column obtains 75% ethanol eluate, 75% ethanol eluate be concentrated under reduced pressure, be freeze-dried after to get
Gardenia Yellow product.
Wherein: the condition of reduced pressure refers to that temperature is 50 DEG C.
The condition of freeze-drying refers to that temperature is -55 DEG C, vacuum degree 0.5MPa.
The separation method of anti-high altitude anoxia anti-fatigue activity ingredient in 2 cape jasmine of embodiment, comprising the following steps:
Will drying, be crushed to the cape jasmine fruits of 30 mesh distillation water boiling and extraction after, through filtering, reduceds pressure, be sprayed
Drying is to get gardenia powder.
Wherein: decocting extraction conditions and refer to that feed liquid mass ratio (g/g) is 1:10, temperature is 100 DEG C, and number is 3 times, every time
Time is 1 hour.
The condition of reduced pressure refers to that temperature is 80 DEG C.
The condition of spray drying refers to that temperature is 140 DEG C, 30 m of unit time intake3, atomisation pressure 0.4MPa.
(2) gardenia powder is configured to the aqueous solution of 30 mg/mL with 25 DEG C of distilled water.
(3) by step, (2) resulting aqueous solution presses 3.0 times of column volume with processed 30 mesh of flow velocity injection of 15mL/min
Polyamide column, then the column volume for pressing 3.0 times are respectively obtained poly- with the flow velocity of 10.0 mL/min distilled water flushing polyamide column
Amide column loading efflux, water elution.
Wherein: processed polyamide column is the same as embodiment 1.
(4) after polyamide loading efflux and water elution being merged, amalgamation liquid with the flow velocity whole injection of 10mL/min at
The macroporous resin column managed, first by 3.0 times of column volume with the flow velocity of 10.0 mL/min distilled water flushing macroporous resin column,
Macroporous resin column is rinsed with the ethanol solution that the flow velocity volumetric concentration of 10.0 mL/min is 10% by 10.0 times of column volume again,
Obtain 10% ethanol eluate, 10% ethanol eluate be concentrated under reduced pressure, be freeze-dried after to get Gardenoside product.
Wherein: macroporous resin column refers to HPD100 type macroreticular resin.
The condition of reduced pressure refers to that temperature is 80 DEG C.
The condition of freeze-drying refers to that temperature is 20 DEG C, and vacuum degree is 0.2 MPa.
Processed macroporous resin column is the same as embodiment 1.
(5) first rinsed by 3.0 times of column volume with the ethanol solution that the flow velocity volumetric concentration of 10.0mL mL/min is 30%
Polyamide column removal of impurities, then rushed by 10.0 times of column volume with the ethanol solution that the flow velocity volumetric concentration of 10.0 mL/min is 30%
The polyamide column is washed, 30% ethanol eluate is obtained, after which is concentrated under reduced pressure, is freeze-dried, i.e.,
Obtain Gardenia Yellow product.
Wherein: the condition of reduced pressure refers to that temperature is 80 DEG C.
The condition of freeze-drying refers to that temperature is 20 DEG C, and vacuum degree is 0.2 MPa.
The separation method of anti-high altitude anoxia anti-fatigue activity ingredient in 3 cape jasmine of embodiment, comprising the following steps:
Will drying, be crushed to the cape jasmine fruits of 40 mesh distillation water boiling and extraction after, through filtering, reduceds pressure, be sprayed
Drying is to get gardenia powder.
Wherein: decocting extraction conditions and refer to that feed liquid mass ratio (g/g) is 1:9, temperature is 95 DEG C, and number is 2 times, when each
Between be 1 hour.
The condition of reduced pressure refers to that temperature is 60 DEG C.
The condition of spray drying refers to that temperature is 130 DEG C, 25 m of unit time intake3, atomisation pressure 0.2MPa.
(2) gardenia powder is configured to the aqueous solution of 40 mg/mL with 25 DEG C of distilled water.
(3) by step, (2) resulting aqueous solution presses 2.0 times of column volume with processed 20 mesh of flow velocity injection of 5mL/min
Polyamide column, then the column volume for pressing 2.0 times respectively obtain polyamides with the flow velocity of 8.0 mL/min distilled water flushing polyamide column
Amine column loading efflux, water elution.
Wherein: processed polyamide column is the same as embodiment 1.
(4) after polyamide loading efflux and water elution being merged, amalgamation liquid with the flow velocity whole injection of 10mL/min at
The macroporous resin column managed, first by 2.0 times of column volume with the flow velocity of 8.0 mL/min distilled water flushing macroporous resin column, then
Macroporous resin column is rinsed with the ethanol solution that the flow velocity volumetric concentration of 5.0 mL/min is 30% by 6.0 times of column volume, is obtained
30% ethanol eluate, 30% ethanol eluate be concentrated under reduced pressure, be freeze-dried after to get Gardenoside product.
Wherein: macroporous resin column refers to XDA-6 type macroreticular resin.
The condition of reduced pressure refers to that temperature is 60 DEG C.
The condition of freeze-drying refers to that temperature is -30 DEG C, and vacuum degree is 0.3 MPa.
Processed macroporous resin column is the same as embodiment 1.
(5) first rinsed by 2.0 times of column volume with the ethanol solution that the flow velocity volumetric concentration of 8.0mL mL/min is 15%
Polyamide column removal of impurities, then rinsed by 6.0 times of column volume with the ethanol solution that the flow velocity volumetric concentration of 5.0 mL/min is 50%
The polyamide column obtains 50% ethanol eluate, 50% ethanol eluate be concentrated under reduced pressure, be freeze-dried after to get
Gardenia Yellow product.
Wherein: the condition of reduced pressure refers to that temperature is 60 DEG C.
The condition of freeze-drying refers to that temperature is -30 DEG C, and vacuum degree is 0.3 MPa.
The separation method of anti-high altitude anoxia anti-fatigue activity ingredient in 4 cape jasmine of embodiment, comprising the following steps:
Will drying, be crushed to the cape jasmine fruits of 20 mesh distillation water boiling and extraction after, through filtering, reduceds pressure, be sprayed
Drying is to get gardenia powder.
Wherein: decocting extraction conditions and refer to that feed liquid mass ratio (g/g) is 1:8.5, temperature is 92 DEG C, and number is 3 times, every time
Time is 1 hour.
The condition of reduced pressure refers to that temperature is 70 DEG C.
The condition of spray drying refers to that temperature is 125 DEG C, 20 m of unit time intake3, atomisation pressure 0.3MPa.
(2) gardenia powder is configured to the aqueous solution of 20 mg/mL with 25 DEG C of distilled water.
(3) by step, (2) resulting aqueous solution presses 1.5 times of column volume with processed 25 mesh of flow velocity injection of 10mL/min
Polyamide column, then the column volume for pressing 1.5 times respectively obtain polyamides with the flow velocity of 6.0 mL/min distilled water flushing polyamide column
Amine column loading efflux, water elution.
Wherein: processed polyamide column is the same as embodiment 1.
(4) after polyamide loading efflux and water elution being merged, amalgamation liquid with the flow velocity whole injection of 10mL/min at
The macroporous resin column managed, first by 1.5 times of column volume with the flow velocity of 6.0 mL/min distilled water flushing macroporous resin column, then
Macroporous resin column is rinsed with the ethanol solution that the flow velocity volumetric concentration of 3.0 mL/min is 50% by 4.0 times of column volume, is obtained
50% ethanol eluate, 50% ethanol eluate be concentrated under reduced pressure, be freeze-dried after to get Gardenoside product.
Wherein: macroporous resin column refers to DM-130 type macroreticular resin.
The condition of reduced pressure refers to that temperature is 70 DEG C.
The condition of freeze-drying refers to that temperature is -10 DEG C, and vacuum degree is 0.4 MPa.
Processed macroporous resin column is the same as embodiment 1.
(5) first rinsed by 1.5 times of column volume with the ethanol solution that the flow velocity volumetric concentration of 6.0mL mL/min is 20%
Polyamide column removal of impurities, then rinsed by 4.0 times of column volume with the ethanol solution that the flow velocity volumetric concentration of 3.0 mL/min is 75%
The polyamide column obtains 75% ethanol eluate, 75% ethanol eluate be concentrated under reduced pressure, be freeze-dried after to get
Gardenia Yellow product.
Wherein: the condition of reduced pressure refers to that temperature is 70 DEG C.
The condition of freeze-drying refers to that temperature is -10 DEG C, and vacuum degree is 0.4 MPa.
The separation method of anti-high altitude anoxia anti-fatigue activity ingredient in 5 cape jasmine of embodiment, comprising the following steps:
Will drying, be crushed to the cape jasmine fruits of 40 mesh distillation water boiling and extraction after, through filtering, reduceds pressure, be sprayed
Drying is to get gardenia powder.
Wherein: decocting extraction conditions and refer to that feed liquid mass ratio (g/g) is 1:9.5, temperature is 98 DEG C, and number is 2 times, every time
Time is 1 hour.
The condition of reduced pressure refers to that temperature is 80 DEG C.
The condition of spray drying refers to that temperature is 140 DEG C, 25 m of unit time intake3, atomisation pressure 0.1MPa.
(2) gardenia powder is configured to the aqueous solution of 40 mg/mL with 25 DEG C of distilled water.
(3) by step, (2) resulting aqueous solution presses 2.5 times of column volume with processed 30 mesh of flow velocity injection of 12mL/min
Polyamide column, then the column volume for pressing 2.5 times respectively obtain polyamides with the flow velocity of 9.0 mL/min distilled water flushing polyamide column
Amine column loading efflux, water elution.
Wherein: processed polyamide column is the same as embodiment 1.
(4) after polyamide loading efflux and water elution being merged, amalgamation liquid with the flow velocity whole injection of 10mL/min at
The macroporous resin column managed, first by 2.5 times of column volume with the flow velocity of 9.0 mL/min distilled water flushing macroporous resin column, then
Macroporous resin column is rinsed with the ethanol solution that the flow velocity volumetric concentration of 8.0 mL/min is 70% by 6.0 times of column volume, is obtained
70% ethanol eluate, 70% ethanol eluate be concentrated under reduced pressure, be freeze-dried after to get Gardenoside product.
Wherein: macroporous resin column refers to DA201 type macroreticular resin.
The condition of reduced pressure refers to that temperature is 80 DEG C.
The condition of freeze-drying refers to that temperature is 10 DEG C, vacuum degree 0.4MPa.
Processed macroporous resin column is the same as embodiment 1.
(5) first rinsed by 2.5 times of column volume with the ethanol solution that the flow velocity volumetric concentration of 9.0mL mL/min is 25%
Polyamide column removal of impurities, then rinsed by 8.0 times of column volume with the ethanol solution that the flow velocity volumetric concentration of 8.0 mL/min is 90%
The polyamide column obtains 90% ethanol eluate, 90% ethanol eluate be concentrated under reduced pressure, be freeze-dried after to get
Gardenia Yellow product.
Wherein: the condition of reduced pressure refers to that temperature is 80 DEG C.
The condition of freeze-drying refers to that temperature is 10 DEG C, vacuum degree 0.4MPa.
The Gardenia Yellow extracted in above-described embodiment 1 ~ 5 refers to as the application of Substituted phenyl-lactic acid ingredient in medicine:
Using Gardenia Yellow as active constituent, it is equipped with any dosage form that medicinal stone is prepared into pharmacy;Or with cape jasmine yellow
Element is active constituent, adds anti-oxidant and/or anti-fatigue active at being grouped as compound, and be equipped with pharmaceutic adjuvant and be prepared into pharmacy
On any dosage form.Dosage form refer to hard capsule, soft capsule, ordinary tablet, sugar coated tablet, Film coated tablets, special-shaped tablets, chewable tablets,
Effervescent tablet, dispersible tablet, granule, pill, solution, any one in syrup.
Embodiment 6 mixes 1 ~ 5 gained Gardenia Yellow of embodiment and cistanche extracts according to the ratio of 1:1,
Capsule is made into using practice of pharmacy, for preventing and treating high altitude anoxia type fatigue.
Embodiment 7 mixes 1 ~ 5 gained Gardenia Yellow of embodiment and cistanche extracts according to the ratio of 3:1,
Dispersible tablet is made into using practice of pharmacy, for preventing and treating high altitude anoxia type fatigue.
Embodiment 8 mixes 1 ~ 5 gained Gardenia Yellow of embodiment and cistanche extracts according to the ratio of 5:1,
Granule is made into using practice of pharmacy, for preventing and treating high altitude anoxia type fatigue.
Embodiment 9 mixes 1 ~ 5 gained Gardenia Yellow of embodiment and cistanche extracts according to the ratio of 7:1,
Pill is made into using practice of pharmacy, for preventing and treating high altitude anoxia type fatigue.
Embodiment 10 mixes 1 ~ 5 gained Gardenia Yellow of embodiment and cistanche extracts according to the ratio of 1:3
It closes, solution is made into using practice of pharmacy, for preventing and treating high altitude anoxia type fatigue.
Obtained Gardenia Yellow can be used as anti-oxidant, anti-fatigue effect active constituent and exist in above-described embodiment 1 ~ 5
Prepare the application in terms of anti-oxidant or anti-fatigue health-product containing.
Claims (10)
1. the separation method of anti-high altitude anoxia anti-fatigue activity ingredient in cape jasmine, comprising the following steps:
Will drying, be crushed to the cape jasmine fruits of 20 ~ 40 mesh distillation water boiling and extraction after, through filtering, reduceds pressure, by spraying do
It is dry to get gardenia powder;
(2) the gardenia powder is configured to the aqueous solution of 20 ~ 40 mg/mL with 25 DEG C of distilled water;
(3) by the step, (2) resulting aqueous solution presses 1.0 ~ 3.0 times of column volume with the flow velocity injection 8cm of 1.5 ~ 15mL/min
Processed 14 ~ 30 mesh polyamide column of × 100 cm, then 1.0 ~ 3.0 times of column volume is pressed with the flow velocity of 5.0 ~ 10.0 mL/min
With distilled water flushing polyamide column, polyamide column loading efflux, water elution are respectively obtained;
(4) after merging polyamide loading efflux and water elution, amalgamation liquid is all injected processed with the flow velocity of 10mL/min
Macroporous resin column, first by 1.0 ~ 3.0 times of column volume with the flow velocity of 5.0 ~ 10.0 mL/min distilled water flushing macroreticular resin
Column, then press the ethanol solution that 2.0 ~ 10.0 times of column volume is 10 ~ 70% with the flow velocity volumetric concentration of 1.5 ~ 10.0 mL/min
Macroporous resin column is rinsed, obtains 10 ~ 70% ethanol eluate, which is concentrated under reduced pressure, is freeze-dried
Afterwards to get Gardenoside product;
(5) the ethyl alcohol for being first 10 ~ 30% with the flow velocity volumetric concentration of 5.0 ~ 10.0mL mL/min by 1.0 ~ 3.0 times of column volume
Solution rinses polyamide column removal of impurities, then by 2.0 ~ 10.0 times of column volume with the flow velocity volumetric concentration of 1.5 ~ 10.0 mL/min
The polyamide column is rinsed for 30 ~ 90% ethanol solution, obtains 30 ~ 90% ethanol eluate, 30 ~ 90% ethanol elution
Liquid be concentrated under reduced pressure, be freeze-dried after to get Gardenia Yellow product.
2. the separation method of anti-high altitude anoxia anti-fatigue activity ingredient in cape jasmine as described in claim 1, it is characterised in that: described
(1) the middle extraction conditions that decoct refer to that feed liquid mass ratio is 1:8 ~ 10 to step, and temperature is 90 ~ 100 DEG C, and number is 2 ~ 3 times, when each
Between be 1 hour.
3. the separation method of anti-high altitude anoxia anti-fatigue activity ingredient in cape jasmine as described in claim 1, it is characterised in that: described
Step is (1), (4) (5) the middle condition being concentrated under reduced pressure each means that temperature is 50 DEG C ~ 80 DEG C to the step with the step.
4. the separation method of anti-high altitude anoxia anti-fatigue activity ingredient in cape jasmine as described in claim 1, it is characterised in that: described
(1) the middle condition being spray-dried refers to that temperature is 120 ~ 140 DEG C to step, 20 ~ 30 m of unit time intake3, atomisation pressure 0.1 ~
0.4MPa。
5. the separation method of anti-high altitude anoxia anti-fatigue activity ingredient in cape jasmine as described in claim 1, it is characterised in that: described
(4) (5) the middle condition being freeze-dried each means that temperature is -55 DEG C ~ 20 DEG C to step with the step, and vacuum degree is 0.2MPa ~ 0.5
MPa。
6. the separation method of anti-high altitude anoxia anti-fatigue activity ingredient in cape jasmine as described in claim 1, it is characterised in that: described
Step (4) in macroporous resin column refer to any one in D-101, HPD100, XDA-6, DM-130, DA201 type macroreticular resin.
7. the separation method of anti-high altitude anoxia anti-fatigue activity ingredient in cape jasmine as described in claim 1, it is characterised in that: described
Step (3) in processed polyamide column and the step (4) in processed macroporous resin column each mean and first use volumetric concentration
For 95% ethanol elution, until ethanol eluate adds distilled water muddiness do not occur, then to distill water elution pillar to no alcohol
Taste to get.
8. the obtained cape jasmine yellow of the separation method of anti-high altitude anoxia anti-fatigue activity ingredient in cape jasmine as described in claim 1
Application of the element as Substituted phenyl-lactic acid ingredient in medicine preparation, it is characterised in that: using Gardenia Yellow as active constituent, be equipped with
Medicinal stone is prepared into any dosage form in pharmacy;Or using Gardenia Yellow as active constituent, add it is anti-oxidant and/or
Anti-fatigue active is equipped with any dosage form that pharmaceutic adjuvant is prepared into pharmacy at being grouped as compound.
9. the obtained cape jasmine yellow of the separation method of anti-high altitude anoxia anti-fatigue activity ingredient in cape jasmine as claimed in claim 8
Application of the element as Substituted phenyl-lactic acid ingredient in medicine preparation, it is characterised in that: the dosage form refer to hard capsule, soft capsule,
Ordinary tablet, sugar coated tablet, Film coated tablets, special-shaped tablets, chewable tablets, effervescent tablet, dispersible tablet, granule, pill, solution, syrup
In any one.
10. the obtained Gardenia Yellow of separation method of anti-high altitude anoxia anti-fatigue activity ingredient in cape jasmine as described in claim 1
Application of the pigment as anti-oxidant, anti-fatigue effect active constituent in terms of preparing anti-oxidant or anti-fatigue health-product containing.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610305926.0A CN105963389B (en) | 2016-05-10 | 2016-05-10 | The separation method of anti-high altitude anoxia anti-fatigue activity ingredient and its application in cape jasmine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610305926.0A CN105963389B (en) | 2016-05-10 | 2016-05-10 | The separation method of anti-high altitude anoxia anti-fatigue activity ingredient and its application in cape jasmine |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105963389A CN105963389A (en) | 2016-09-28 |
CN105963389B true CN105963389B (en) | 2019-05-24 |
Family
ID=56991519
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610305926.0A Active CN105963389B (en) | 2016-05-10 | 2016-05-10 | The separation method of anti-high altitude anoxia anti-fatigue activity ingredient and its application in cape jasmine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105963389B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107648345A (en) * | 2017-09-14 | 2018-02-02 | 李茂星 | A kind of Chinese medicine composition with anti-high altitude anoxia fatigue effect |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1807441A (en) * | 2006-02-23 | 2006-07-26 | 江南大学 | Method for producing high purity jasminoidin and high color number gardenia yellow pigment |
CN1939458A (en) * | 2006-09-30 | 2007-04-04 | 福州大学 | Preparation of gardenia jasminoides by macroporous adsorbing resin |
CN101411466A (en) * | 2008-11-24 | 2009-04-22 | 浙江省中药研究所有限公司 | Method for preparing cape jasmine yellow pigment using cape jasmine as raw material |
CN102732050A (en) * | 2012-06-06 | 2012-10-17 | 浙江科技学院 | Method for preparing gardenia pigments from Gardenia jasminoides Ellis |
CN103951718A (en) * | 2014-04-12 | 2014-07-30 | 云南云药医药研究有限公司 | Method used for preparing high-purity gardenoside and crocin from gardenia jasminoides ellis |
-
2016
- 2016-05-10 CN CN201610305926.0A patent/CN105963389B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1807441A (en) * | 2006-02-23 | 2006-07-26 | 江南大学 | Method for producing high purity jasminoidin and high color number gardenia yellow pigment |
CN1939458A (en) * | 2006-09-30 | 2007-04-04 | 福州大学 | Preparation of gardenia jasminoides by macroporous adsorbing resin |
CN101411466A (en) * | 2008-11-24 | 2009-04-22 | 浙江省中药研究所有限公司 | Method for preparing cape jasmine yellow pigment using cape jasmine as raw material |
CN102732050A (en) * | 2012-06-06 | 2012-10-17 | 浙江科技学院 | Method for preparing gardenia pigments from Gardenia jasminoides Ellis |
CN103951718A (en) * | 2014-04-12 | 2014-07-30 | 云南云药医药研究有限公司 | Method used for preparing high-purity gardenoside and crocin from gardenia jasminoides ellis |
Non-Patent Citations (1)
Title |
---|
高色价栀子黄色素提取工艺及其性质研究;杨瑞云;《西北师范大学学报(自然科学版)》;20020331;全文 |
Also Published As
Publication number | Publication date |
---|---|
CN105963389A (en) | 2016-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102114044B (en) | Artificially processed bear bile powder and preparation method thereof | |
CN104418744B (en) | A kind of new salvianolic acid compound T, Preparation Method And The Use | |
CN101244110B (en) | Preparation method of Chinese medicine composition with function of releasing fatigue, reinforcing immunity | |
CN108670979A (en) | Adjust-blood lipid norcholesterol prevents the bear gall powder of cardiovascular and cerebrovascular diseases and atherosclerosis | |
CN105582000A (en) | Preparation method of terpenoid and lignan substances in eucommia ulmoides bark or eucommia ulmoides leaves and application of terpenoid and lignan substances in preparation of senile dementia treatment drug | |
CN108578433A (en) | For preventing or treating gall stone cholecystitis and improve the bear gall powder of gallbladder function | |
CN108743621A (en) | The bear gall powder and preparation method of ice crystal state | |
CN103156193A (en) | Coenzyme Q10 soft capsules and preparation method thereof | |
CN108635375A (en) | Prevent or treats hepatopathy and liver fibrosis and improve the bear gall powder and purposes of liver function | |
KR100699790B1 (en) | Pharmaceutical composition for the prevention and treatment of liver disease comprising a Lonicera caerulea L. var. edulis extract | |
AU2005204044B2 (en) | Antiaging composition | |
US20050154066A1 (en) | Antiaging composition | |
CN105963389B (en) | The separation method of anti-high altitude anoxia anti-fatigue activity ingredient and its application in cape jasmine | |
KR20020092082A (en) | Tonic composition | |
CN104286844B (en) | A kind of improve the food of immunity, health product or pharmaceutical composition | |
CN114748566B (en) | Anti-alcohol liver-protecting composition and application thereof | |
CN109864987A (en) | Application of the Quercetin in the drug of preparation protection and the hepatic injury of medicine physical property | |
CN102260340B (en) | Chinese magnoliavine protein, and preparation method and medicinal application thereof | |
CN115487221A (en) | Medicine and food dual-purpose composition for resisting blue light injury of retina and preparation method and application thereof | |
CN104367612B (en) | A kind of application of dog ant grass extract | |
CN108379446B (en) | Coenzyme Q10 preparation for adjuvant treatment of male oligospermia and preparation method thereof | |
CN108379252B (en) | Gooseberry anthocyanidin is preparing the application in anti-hepatic fibrosis drug or health care product | |
CN102258620B (en) | Chinese medicinal injection for treating mixed infection of swine streptococcus and swine fever and preparation method thereof | |
RU2436415C2 (en) | Composition of biologically active substances based on betulin with regulated rate of releasing components for reducing degree of alcohol intoxication, preventing and relieving alcohol intoxication and alcohol withdrawal syndrome | |
CN112007092A (en) | Anti-alcohol composition and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191203 Address after: 730050, No. 333 Binhe Road, Qilihe District, Gansu, Lanzhou Patentee after: Ninety-fourth O Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army Address before: Peace road 730050 Gansu city of Lanzhou province No. 818 Xinyuan District 8 Building 1801 Patentee before: Li Maoxing |
|
TR01 | Transfer of patent right |